Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. - Ma, Dongjie; Li, Shanqing; Cui, Yushang; Li, Li; Liu, Hongsheng; Chen, Yeye; Zhou, Xiaoyun (Oncology Letters, 2021)